iBio, Inc. Common Stock (IBIO) financials · rev $100.0K
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
iBio, Inc. Common Stock (IBIO) rev $100.0K.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $100.0K | $400.0K |
| Operating Income | -$35.1M | -$18.6M |
| Net Income | -$32.8M | -$18.4M |
| EPS (Diluted) | -$0.32 | -$1.75 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $99.1M | $23.2M |
| Current Assets | $92.2M | $9.72M |
| Cash & Equivalents | $56.4M | $8.58M |
| PP&E | $3.09M | $3.16M |
| Total Liabilities | $13.4M | $8.30M |
| Current Liabilities | $11.7M | $6.11M |
| Shareholders' Equity | $85.7M | $14.9M |
| Retained Earnings | -$365.3M | -$332.2M |
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$23.2M | -$15.3M |
| CapEx | $578.0K | $16.0K |
| Investing Cash Flow | -$32.0M | $742.0K |
| Financing Cash Flow | $103.0M | $8.93M |
| Net Change in Cash | $47.8M | -$5.63M |
| Free Cash Flow | -$23.8M | -$15.3M |
FAQ
What is IBIO P/E and revenue?
iBio, Inc. Common Stock (IBIO) rev $100.0K.
What is IBIO revenue?
iBio, Inc. Common Stock last cached revenue is $100.0K (FY2026).
Is IBIO profitable?
iBio, Inc. Common Stock last cached net income is -$32.8M (FY2026).
What are IBIO total assets?
iBio, Inc. Common Stock last cached total assets are $99.1M (FY2026).
What is IBIO free cash flow?
iBio, Inc. Common Stock last cached free cash flow is -$23.8M (FY2026).
Not investment advice. Cached statements, not a live tape.